Tianjin Ringpu Bio-Technology Co.,Ltd.
SHZ: 300119.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Lei Xu
- Employees
- 2,496
- Headquarters
- Tianjin, China
- IPO year
- 2010
- Market cap
- CN¥8.3B
- Website
- https://www.ringpu.com
Loading 300119…
Loading profile data…Frequently asked questions about 300119
What does Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) do?
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sales of veterinary biological products, veterinary drug preparations, functional additives, and veterinary raw materials in China. The company provides vaccines and drugs for poultry, swine, and other animals; pet products comprising pet rabies inact...
Where does 300119.SZ trade?
Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300119.SZ in?
Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tianjin Ringpu Bio-Technology Co.,Ltd.?
Lei Xu is the chief executive officer of Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ).
Where is Tianjin Ringpu Bio-Technology Co.,Ltd. headquartered?
Tianjin Ringpu Bio-Technology Co.,Ltd. is headquartered in China.
Does 300119.SZ pay a dividend?
Yes — Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) paid a trailing twelve-month dividend of CNY 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300119.SZ go public?
Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) completed its initial public offering in 2010.